Sai Life Science Results Update
Sai Life Sciences reported FY26 revenue of ₹2,192 Crore, representing 29% growth. Net profit doubled to ₹355 Crore, driven by deep engagement with large pharma customers.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Sai Life Sciences reported FY26 revenue of ₹2,192 Crore, representing 29% growth. Net profit doubled to ₹355 Crore, driven by deep engagement with large pharma customers.
Sai Life Science Ltd reported revenue from operations of ₹602.1 Cr (+3.9% YoY) and net profit of ₹104.2 Cr (+18.0% YoY) for Q4 FY26.
Sai Life Sciences approved its FY2026 audited financial results. Consolidated annual revenue reached ₹21,924.92 million, reflecting significant year-on-year growth and strong operational performance.